Government Owned Invention Available for License: Human Antibodies Targeting Beneficial Viral Peptide in Liver Cancer
Notice
Health and Human Services Department, National Institutes of Health
Notice
August 12, 2026
2026-16442
📄 Summary
The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop a collection of anti- CE1 antibodies for liver cancer treatment.
